SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Immunoglobulin A Targeting on the N-Terminal Moiety of Viral Phosphoprotein Prevents Measles Virus from Evading Interferon-β Signaling.

Yang, Y; Zhou, D; Zhao, B; Cao, Y; Yu, J; Yan, H; Zhao, W; Zhang, E; Yang, J; Zhong, M; et al. Yang, Y; Zhou, D; Zhao, B; Cao, Y; Yu, J; Yan, H; Zhao, W; Zhang, E; Yang, J; Zhong, M; Hu, Q; Deng, L; Yan, H (2020) Immunoglobulin A Targeting on the N-Terminal Moiety of Viral Phosphoprotein Prevents Measles Virus from Evading Interferon-β Signaling. ACS Infect Dis, 6 (5). pp. 844-856. ISSN 2373-8227 https://doi.org/10.1021/acsinfecdis.9b00427
SGUL Authors: Hu, Qinxue

[img] Microsoft Word (.doc) Accepted Version
Available under License ["licenses_description_publisher" not defined].

Download (411kB)

Abstract

Immunoglobulin A (IgA) can inhibit intracellular viral replication during its transport across the epithelial cells. We find a monoclonal IgA antibody 7F1-IgA against the N-terminal moiety of the phosphoprotein (PNT) of measles virus (MV), which inhibits the intracellular replication of MV in Caco-2 cells but not in interferon-deficient Vero-pIgR cells. Transcytosis of 7F1-IgA across the MV-infected Caco-2 cells enhances the production of interferon-β (IFN-β) and the expression of IFN-stimulated genes, rendering Caco-2 cells with higher antiviral immunity. 7F1-IgA specifically interacts with MV phosphoprotein inside the MV-infected Caco-2 cell and prevents MV phosphoprotein from inhibiting the phosphorylation of JAK1 and STAT1. The intraepithelial interaction between 7F1-IgA and the viral phosphoprotein results in an earlier and stronger phosphorylation of JAK1 and STAT1 and, consequently, a more efficient nuclear translocation of STAT1 for the activation of the type I interferon pathway. Thus, IgA against phosphoprotein prevents a virus from evading type I IFN signaling and confers host epithelial cells efficient innate antiviral immunity, which potentiates a new antiviral target and an antiviral strategy.

Item Type: Article
Additional Information: This document is the Accepted Manuscript version of a Published Work that appeared in final form in ACS Infectious Diseases, copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see https://doi.org/10.1021/acsinfecdis.9b00427
Keywords: IgA, N-terminal moiety of viral phosphoprotein, intracellular neutralization, measles virus, type I interferon
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: ACS Infect Dis
ISSN: 2373-8227
Language: eng
Dates:
DateEvent
8 May 2020Published
2 March 2020Published Online
2 March 2020Accepted
Publisher License: Publisher's own licence
Projects:
Project IDFunderFunder ID
31670932National Natural Science Foundation of Chinahttp://dx.doi.org/10.13039/501100001809
31200689National Natural Science Foundation of Chinahttp://dx.doi.org/10.13039/501100001809
81461130019National Natural Science Foundation of Chinahttp://dx.doi.org/10.13039/501100001809
2016YFC1201004National Key R&D ProgramUNSPECIFIED
2017B020226006Special Funding for Science and Technology Development of Guangdong ProvinceUNSPECIFIED
PubMed ID: 32119519
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/111906
Publisher's version: https://doi.org/10.1021/acsinfecdis.9b00427

Actions (login required)

Edit Item Edit Item